Viridicatumtoxin B
Viridicatumtoxin B is a tetracycline-class antibiotic produced by the fungus Penicillium citreonigrum. It is a potent inhibitor of bacterial protein synthesis, and has been studied for its potential use in the treatment of bacterial infections.
Structure and Synthesis[edit | edit source]
Viridicatumtoxin B is a macrolide with a 12-membered ring structure. It is synthesized by the fungus Penicillium citreonigrum through a series of enzyme-catalyzed reactions. The biosynthetic pathway involves the formation of a polyketide chain, which is then cyclized to form the macrolide ring. The final steps involve the addition of a sugar moiety and a methyl group to complete the structure.
Mechanism of Action[edit | edit source]
Viridicatumtoxin B inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the aminoacyl-tRNA from attaching to the A site. This blocks the elongation of the polypeptide chain, leading to the termination of protein synthesis.
Potential Medical Uses[edit | edit source]
Due to its potent antibacterial activity, Viridicatumtoxin B has been studied for its potential use in the treatment of bacterial infections. However, further research is needed to determine its safety and efficacy in humans.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD